FDA Inspection 721599 — Regenerative Biologics, Inc.

Regenerative Biologics, Inc. — FEI 3003567004

The FDA completed an inspection of Regenerative Biologics, Inc. on April 20, 2011 in Gainesville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 20, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Gainesville, FL (United States)